ATE175203T1 - Sulfatierte glykolipide, die eine galaktose-3-0- sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum - Google Patents

Sulfatierte glykolipide, die eine galaktose-3-0- sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum

Info

Publication number
ATE175203T1
ATE175203T1 AT92910435T AT92910435T ATE175203T1 AT E175203 T1 ATE175203 T1 AT E175203T1 AT 92910435 T AT92910435 T AT 92910435T AT 92910435 T AT92910435 T AT 92910435T AT E175203 T1 ATE175203 T1 AT E175203T1
Authority
AT
Austria
Prior art keywords
individual
galactose
methods
sulfate
prediabetis
Prior art date
Application number
AT92910435T
Other languages
English (en)
Inventor
Karsten Buschard
Original Assignee
A & Science Invest Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A & Science Invest Ab filed Critical A & Science Invest Ab
Application granted granted Critical
Publication of ATE175203T1 publication Critical patent/ATE175203T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT92910435T 1991-05-07 1992-05-07 Sulfatierte glykolipide, die eine galaktose-3-0- sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum ATE175203T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK91846A DK84691D0 (da) 1991-05-07 1991-05-07 Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater

Publications (1)

Publication Number Publication Date
ATE175203T1 true ATE175203T1 (de) 1999-01-15

Family

ID=8098211

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92910435T ATE175203T1 (de) 1991-05-07 1992-05-07 Sulfatierte glykolipide, die eine galaktose-3-0- sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum

Country Status (9)

Country Link
US (1) US5827828A (de)
EP (1) EP0584175B1 (de)
JP (1) JP3222465B2 (de)
AT (1) ATE175203T1 (de)
AU (1) AU1788892A (de)
DE (1) DE69228061T2 (de)
DK (2) DK84691D0 (de)
ES (1) ES2125898T3 (de)
WO (1) WO1992019633A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580858A (en) * 1991-06-10 1996-12-03 Alberta Research Council Immunosuppressive and tolerogenic modified Lewisx compounds
CA2142153A1 (en) * 1994-03-04 1995-09-05 Jacques Banville Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors
US5663151A (en) * 1994-03-04 1997-09-02 Bristol-Myers Squibb Company Sulfated α-glycolipid derivatives as cell adhesion inhibitors
US5686426A (en) 1994-11-17 1997-11-11 Bristol-Myers Squibb Company Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
SE9601817D0 (sv) 1996-05-13 1996-05-13 Karsten Buschard Novel glycolipid complexex and their uses
EP0988860B1 (de) * 1997-04-10 2005-01-12 Kirin Beer Kabushiki Kaisha Verwendung von a-Glycosylceramiden zur Herstellung eines therapeutischen Mittelszur Behandlung von Autoimmunkrankheiten
JP2001527046A (ja) 1997-12-30 2001-12-25 エイプラス サイエンス インベスト アーベー ガラクトシルセラミド、グルコシルセラミド、ラクトシルセラミド、並びに前糖尿病、糖尿病および／または関連合併症の予防もしくは治療に使用するためのその特定キャッチャー
SE0000258D0 (sv) * 2000-01-27 2000-01-27 A & Science Invest Ab Pharmaceutical preparation and method for treatment of diabetes
US8367623B2 (en) * 2001-08-16 2013-02-05 Japan As Represented By President Of National Center Of Neurology And Psychiatry Glycolipid and medicine for autoimmune disease containing the same as active ingredient
JP5564672B2 (ja) 2006-06-30 2014-07-30 ザ スクリプス リサーチ インスティテュート アジュバント及びその使用方法
FR2926972B1 (fr) * 2008-02-05 2011-03-11 Technologia Appareil de diagnostic precoce du syndrome du canal carpien et procede et dispositif d'acquisition de l'information relative a la sensibilite cutanee du doigt du patient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288706A (en) * 1987-12-25 1994-02-22 Mitsui Toatsu Chemicals, Incorporated Medicament for prevention and remedy of diseases of the pancreas and others

Also Published As

Publication number Publication date
DE69228061D1 (de) 1999-02-11
DK0584175T3 (da) 1999-08-30
JPH06506943A (ja) 1994-08-04
DK84691D0 (da) 1991-05-07
US5827828A (en) 1998-10-27
WO1992019633A1 (en) 1992-11-12
AU1788892A (en) 1992-12-21
JP3222465B2 (ja) 2001-10-29
ES2125898T3 (es) 1999-03-16
DE69228061T2 (de) 1999-05-27
EP0584175B1 (de) 1998-12-30
EP0584175A1 (de) 1994-03-02

Similar Documents

Publication Publication Date Title
Lipper et al. Preliminary study of carbamazepine in post-traumatic stress disorder
ATE175203T1 (de) Sulfatierte glykolipide, die eine galaktose-3-0- sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum
Ashbrook et al. Medium chain fatty acid binding to human plasma albumin
Kochian et al. Potassium transport in corn roots: I. Resolution of kinetics into a saturable and linear component
Marples et al. Ecological effects of oral antibiotics on the microflora of human skin
Olsen et al. The intestinal brush border membrane in diabetes: studies of sucrase-isomaltase metabolism in rats with streptozotocin diabetes
Paulev et al. Motor nerve conduction velocity in asymptomatic lead workers
Nordlind Further studies on the ability of different metal salts to influence the DNA synthesis of human lymphoid cells
CA2072368A1 (en) Methods for diagnosing human influenza and 4-position modified chromogenic n-acetylneuraminic acid substrates for use therein
Lindberg et al. Urinary excretion of chromium in chromeplaters after discontinued exposure
Lorente et al. A simple and reproducible method to evaluate granulocyte adherence
NO146922C (no) Testremse for bestemmelse av glucose og galactose i blod og urin samt okkult blod i faeces
Chuong et al. The MMPI as an aid in evaluating patients with premenstrual syndrome
JPS5352271A (en) Method and device for cold processing of metal plate by double action in single operatinal stage
Ohnishi et al. Changes in [3H] Nitrendipine Binding and γ‐Aminobutyric Acid Release in Rat Hippocampus Following Repeated Morphine Administration
HAYASHI Histological and histochemical study of the early lesions of mouse skin after a single application of 4-nitroquinoline N-oxide
Wang et al. Plasma arginase concentration measured by an enzyme-linked immunosorbent assay (ELISA) in normal adult population
Whitehead et al. Metabolites of phenylalanine in the urine of children with kwashiorkor
Spisani et al. Effect of antiinflammatory agents on neutrophil superoxide production in rheumatoid arthritis
Wu et al. Effect of platelet activation on the platelet surface sialic acid
Gabrieli et al. A clinical study of serum glutamic oxalacetic transaminase isoenzymes in liver diseases
GR980300023T1 (en) Means for treating auto-immune diseases and method of treatment
BR8904681A (pt) Uma linha de celulas de hibridoma,mutantes,anticorpos,processos para a preparacao de uma linha de celulas e para a preparacao de anticorpos e processo e agente para comprovacao imunologica de atrazina
KR950703658A (ko) Hiv감염자 및 그들의 처치 정도를 확인하는 방법 및 진단물질
Lettau et al. Effects of reduced temperature on the components of human lymphocyte transformation responses to antigens

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee